Affiliations
AffiliationsItem in Clipboard
Social determinants of colorectal cancer risk, stage, and survival: a systematic reviewSteven S Coughlin. Int J Colorectal Dis. 2020 Jun.
. 2020 Jun;35(6):985-995. doi: 10.1007/s00384-020-03585-z. Epub 2020 Apr 21. AffiliationsItem in Clipboard
AbstractBackground: Several social determinants of health have been examined in relation to colorectal cancer incidence, stage at diagnosis, and survival including income, education, neighborhood disadvantage, immigration status, social support, and social network. Colorectal cancer incidence rates are positively associated with income and other measures of socioeconomic status. In contrast, low socioeconomic status tends to be associated with poorer survival.
Methods: The present review is based upon bibliographic searches in PubMed and CINAHL and relevant search terms. Articles published in English from 1970 through April 1, 2019 were identified using the following MeSH search terms and Boolean algebra commands: colorectal cancer AND (incidence OR stage OR mortality) AND (social determinants OR neighborhood disadvantage OR racial discrimination OR immigration OR social support).
Results: This review indicates that poverty, lack of education, immigration status, lack of social support, and social isolation play important roles in colorectal cancer stage at diagnosis and survival.
Conclusions: To address social determinants of colorectal cancer, effective interventions are needed that account for the social contexts in which patients live.
Keywords: African Americans; Colorectal cancer; Education; Immigration; Poverty; Social support.
Similar articlesCoughlin SS. Coughlin SS. Breast Cancer Res Treat. 2019 Oct;177(3):537-548. doi: 10.1007/s10549-019-05340-7. Epub 2019 Jul 3. Breast Cancer Res Treat. 2019. PMID: 31270761 Review.
Coughlin SS. Coughlin SS. Prostate Int. 2020 Jun;8(2):49-54. doi: 10.1016/j.prnil.2019.08.001. Epub 2019 Aug 27. Prostate Int. 2020. PMID: 32647640 Free PMC article. Review.
Coughlin SS, Young L. Coughlin SS, et al. Eur j Cardiovasc Res. 2020;1(1):10.31487/j.ejcr.2020.01.02. doi: 10.31487/j.ejcr.2020.01.02. Epub 2020 Sep 18. Eur j Cardiovasc Res. 2020. PMID: 33089252 Free PMC article.
Danos DM, Ferguson TF, Simonsen NR, Leonardi C, Yu Q, Wu XC, Scribner RA. Danos DM, et al. Ann Epidemiol. 2018 May;28(5):316-321.e2. doi: 10.1016/j.annepidem.2018.02.004. Epub 2018 Mar 22. Ann Epidemiol. 2018. PMID: 29678311 Free PMC article.
Degett TH, Christensen J, Thomsen LA, Iversen LH, Gögenur I, Dalton SO. Degett TH, et al. BJS Open. 2020 Feb;4(1):133-144. doi: 10.1002/bjs5.50218. Epub 2019 Nov 4. BJS Open. 2020. PMID: 32011820 Free PMC article.
Álvarez-López D, Morales-Piélago GF, Aguilar-Guerrero F, Pérez-Peralta L, Hernández-Aguilar JM, Reynoso-Noverón N. Álvarez-López D, et al. J Cancer Educ. 2024 Oct 28. doi: 10.1007/s13187-024-02535-5. Online ahead of print. J Cancer Educ. 2024. PMID: 39466590
Cancino RS, Su Z, Mesa R, Tomlinson GE, Wang J. Cancino RS, et al. JMIR Cancer. 2020 Oct 29;6(2):e21697. doi: 10.2196/21697. JMIR Cancer. 2020. PMID: 33027039 Free PMC article.
Adebayo AS, Agbaje K, Adesina SK, Olajubutu O. Adebayo AS, et al. Pharmaceutics. 2023 Nov 12;15(11):2620. doi: 10.3390/pharmaceutics15112620. Pharmaceutics. 2023. PMID: 38004598 Free PMC article. Review.
Collatuzzo G, Teglia F, Boffetta P. Collatuzzo G, et al. Cancers (Basel). 2022 Aug 31;14(17):4259. doi: 10.3390/cancers14174259. Cancers (Basel). 2022. PMID: 36077790 Free PMC article. Review.
Lorentsen MK, Sanoff HK. Lorentsen MK, et al. Curr Treat Options Oncol. 2024 Apr;25(4):453-464. doi: 10.1007/s11864-024-01191-7. Epub 2024 Mar 18. Curr Treat Options Oncol. 2024. PMID: 38498252 Review.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3